VFS
PDLI

VSR Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

VSR Financial Services’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,990
Closed -$92K – 621
2014
Q4 		$92K Buy
11,990
+1,251
+12% +$9.9K 0.01% 554
2014
Q3 		$80K Buy
10,739
+189
+2% +$1.75K 0.01% 572
2014
Q2 		$102K Sell
10,550
-33,216
-76% -$296K 0.01% 553
2014
Q1 		$364K Buy
43,766
+115
+0.3% +$986 0.05% 391
2013
Q4 		$368K Buy
43,651
+5,773
+15% +$48.6K 0.06% 375
2013
Q3 		$302K Buy
37,878
+1,048
+3% +$8.43K 0.05% 387
2013
Q2 		$284K Buy
+36,830
New +$287K 0.06% 376

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Gotham Asset Management
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

VSR Financial Services's PDLI Position: Q1 2015 in Review

VSR Financial Services sold out of PDL BioPharma, Inc. (PDLI) in Q1 2015, closing a stake of 11,990 shares — an estimated $92K sold.

VSR Financial Services first reported a position in PDLI in Q2 2013 and held it in 7 quarters. The position peaked at $368K in Q4 2013. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

  • VSR Financial Services reported no remaining PDL BioPharma, Inc. position as of Q1 2015 after selling out during the quarter.
  • VSR Financial Services sold 11,990 PDL BioPharma, Inc. shares in Q1 2015, an estimated $92K.
  • VSR Financial Services first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 7 quarters.
  • VSR Financial Services's PDL BioPharma, Inc. position peaked at $368K in Q4 2013.
  • 215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on VSR Financial Services's 13F filing for Q1 2015, filed 13 May 2015.